-
1
-
-
0014231954
-
Lymphomatoid papulosis: A continuing self-healing eruption, clinically benign-hematologically malignant
-
Macaulay WL: Lymphomatoid papulosis: a continuing self-healing eruption, clinically benign-hematologically malignant. Arch Dermatol 97:23-31, 1968.
-
(1968)
Arch Dermatol
, vol.97
, pp. 23-31
-
-
Macaulay, W.L.1
-
2
-
-
0345293277
-
CD30+ cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
-
Liu HJL, Hoppe RT, Kohler S, et al: CD30+ cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. J Am Acad Dermatol 1049-1058, 2003.
-
(2003)
J Am Acad Dermatol
, vol.1049-1058
-
-
Liu, H.J.L.1
Hoppe, R.T.2
Kohler, S.3
-
3
-
-
0034660654
-
Primary and secondary cutaneous CD30+ lymphoproliferative disorders: Report from the Dutch Cutaneous Lymphoma group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment
-
Bekkenk MW, Geelen FAMJ, Vader PC, et al: Primary and secondary cutaneous CD30+ lymphoproliferative disorders: Report from the Dutch Cutaneous Lymphoma group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 95:3653-3661, 2000.
-
(2000)
Blood
, vol.95
, pp. 3653-3661
-
-
Bekkenk, M.W.1
Geelen, F.A.M.J.2
Vader, P.C.3
-
4
-
-
0033214851
-
Increased risk of lymphoid and non-lymphoid malignancies in patients with lymphomatoid papulosis
-
Wang HH, Myers T, Lach LJ, et al: Increased risk of lymphoid and non-lymphoid malignancies in patients with lymphomatoid papulosis. Cancer 86:1240-1245,1999.
-
(1999)
Cancer
, vol.86
, pp. 1240-1245
-
-
Wang, H.H.1
Myers, T.2
Lach, L.J.3
-
5
-
-
0027952678
-
Primary Ki-1 positive anaplastic large-cell lymphoma: A distinct clinicopathologic entity
-
Kadin ME: Primary Ki-1 positive anaplastic large-cell lymphoma: A distinct clinicopathologic entity. Ann Oncol 5(suppl 1):25-30, 1994.
-
(1994)
Ann Oncol
, vol.5
, Issue.SUPPL. 1
, pp. 25-30
-
-
Kadin, M.E.1
-
6
-
-
38949085902
-
Prognostic factors in childhood anaplastic large cell lymphoma: Results of a large European intergroup study
-
Le Deley M-C, Reiter A, Williams D, et al: Prognostic factors in childhood anaplastic large cell lymphoma: Results of a large European intergroup study. Blood 111:1560-1566, 2008.
-
(2008)
Blood
, vol.111
, pp. 1560-1566
-
-
Le Deley, M.-C.1
Reiter, A.2
Williams, D.3
-
7
-
-
0027216775
-
Differences in clinical behavior and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null-cell phenotype
-
De Bruin PC, Beljaards RC, van Heerde P, et al: Differences in clinical behavior and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null-cell phenotype. Histopathology 23:127-135, 1993.
-
(1993)
Histopathology
, vol.23
, pp. 127-135
-
-
De Bruin, P.C.1
Beljaards, R.C.2
van Heerde, P.3
-
8
-
-
18544383148
-
Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders
-
Franchina M, Kadin ME, Abraham LW: Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders. Cancer Epidemiol Biomarkers Prev 14:1322-1325, 2005.
-
(2005)
Cancer Epidemiol Biomarkers Prev
, vol.14
, pp. 1322-1325
-
-
Franchina, M.1
Kadin, M.E.2
Abraham, L.W.3
-
10
-
-
1842787079
-
CD30(+) cutaneous lymphoma in association with atopic eczema
-
Fletcher CL, Orchard GE, Hubbard V, et al: CD30(+) cutaneous lymphoma in association with atopic eczema. Arch Dermatol 140:449-454, 2004.
-
(2004)
Arch Dermatol
, vol.140
, pp. 449-454
-
-
Fletcher, C.L.1
Orchard, G.E.2
Hubbard, V.3
-
11
-
-
62549122477
-
Recurrent translocations involving the IRF4 locus in peripheral T-cell lymphomas
-
Feldman AL, Law M, Remstein ED, et al: Recurrent translocations involving the IRF4 locus in peripheral T-cell lymphomas. Leukemia 23:574-580, 2009.
-
(2009)
Leukemia
, vol.23
, pp. 574-580
-
-
Feldman, A.L.1
Law, M.2
Remstein, E.D.3
-
12
-
-
0026755732
-
-
Beljaards RC, Willemze R: The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol 126:596,-602,1992.
-
Beljaards RC, Willemze R: The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol 126:596,-602,1992.
-
-
-
-
13
-
-
0029987036
-
The same dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis
-
Chott A, Vonderheid EC, Olbricht S, et al: The same dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol 106:696-700,1996.
-
(1996)
J Invest Dermatol
, vol.106
, pp. 696-700
-
-
Chott, A.1
Vonderheid, E.C.2
Olbricht, S.3
-
14
-
-
0031695440
-
Lymphomatoid papulosis in association with mycosis fungoides: A study of 15 cases
-
Basarab T, Fraser-Andrews EA, Orchard G, et al: Lymphomatoid papulosis in association with mycosis fungoides: A study of 15 cases. Br J Dermatol 139:680-688, 1998.
-
(1998)
Br J Dermatol
, vol.139
, pp. 680-688
-
-
Basarab, T.1
Fraser-Andrews, E.A.2
Orchard, G.3
-
15
-
-
0026486401
-
Epidemiology of lymphomatoid papulosis
-
Wang HH, Lach L, Kadin ME: Epidemiology of lymphomatoid papulosis. Cancer 70:2951-2957, 1992.
-
(1992)
Cancer
, vol.70
, pp. 2951-2957
-
-
Wang, H.H.1
Lach, L.2
Kadin, M.E.3
-
16
-
-
0033214851
-
Increased risk of lymphoid and non-lymphoid malignancies in patients with lymphomatoid papulosis
-
Wang HH, Myers T, Lach LJ, et al: Increased risk of lymphoid and non-lymphoid malignancies in patients with lymphomatoid papulosis. Cancer 86:1240-1245, 1999.
-
(1999)
Cancer
, vol.86
, pp. 1240-1245
-
-
Wang, H.H.1
Myers, T.2
Lach, L.J.3
-
17
-
-
0029938791
-
A dominant inhibitory mutant of the type II TGF- β receptor in the malignant progression of a cutaneous T-cell lymphoma
-
Knaus P, Lindemann D, De Coteau JF, et al: A dominant inhibitory mutant of the type II TGF- β receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 16:3480-3489, 1996.
-
(1996)
Mol Cell Biol
, vol.16
, pp. 3480-3489
-
-
Knaus, P.1
Lindemann, D.2
De Coteau, J.F.3
-
18
-
-
0032878291
-
A deletion in the gene for transforming growth factor-beta type I receptor abolishes growth regulation by transforming growth factor-beta in a cutaneous T cell lymphoma
-
Schiemann WP, Pfeifer WM, Levi E, et al: A deletion in the gene for transforming growth factor-beta type I receptor abolishes growth regulation by transforming growth factor-beta in a cutaneous T cell lymphoma. Blood 94:2854-2861, 1999.
-
(1999)
Blood
, vol.94
, pp. 2854-2861
-
-
Schiemann, W.P.1
Pfeifer, W.M.2
Levi, E.3
-
19
-
-
0029913823
-
Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders
-
Vonderheid EC, Sajjadian A, Kadin ME: Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol 34:470-481, 1996.
-
(1996)
J Am Acad Dermatol
, vol.34
, pp. 470-481
-
-
Vonderheid, E.C.1
Sajjadian, A.2
Kadin, M.E.3
-
21
-
-
0029855951
-
Th2 cytokine mRNA expression in primary cutaneous CD30-postiive lymphoproliferative disorders: Successful treatment with recombinant interferon-gamma
-
Yagi H, Tokura Y, Furukawas F, et al: Th2 cytokine mRNA expression in primary cutaneous CD30-postiive lymphoproliferative disorders: Successful treatment with recombinant interferon-gamma. J Invest Dermatol 107:827-832, 1996.
-
(1996)
J Invest Dermatol
, vol.107
, pp. 827-832
-
-
Yagi, H.1
Tokura, Y.2
Furukawas, F.3
-
22
-
-
0034307060
-
Therapeutic use of interferon-alpha for lymphomatoid papulosis
-
Schmuth M, Topar G, Illersperger B, et al: Therapeutic use of interferon-alpha for lymphomatoid papulosis. Cancer 89:1603-1610, 2000.
-
(2000)
Cancer
, vol.89
, pp. 1603-1610
-
-
Schmuth, M.1
Topar, G.2
Illersperger, B.3
-
23
-
-
0037276018
-
Bexarotene is a new treatment option for lymphomatoid papulosis
-
Krathen RA, Ward S, Duvic M: Bexarotene is a new treatment option for lymphomatoid papulosis. Dermatology 206:142-147, 2003.
-
(2003)
Dermatology
, vol.206
, pp. 142-147
-
-
Krathen, R.A.1
Ward, S.2
Duvic, M.3
-
24
-
-
0033939507
-
Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin
-
Drews R, Samel A, Kadin ME: Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin. Semin Cutan Med Surg 19:109-117, 2000.
-
(2000)
Semin Cutan Med Surg
, vol.19
, pp. 109-117
-
-
Drews, R.1
Samel, A.2
Kadin, M.E.3
-
25
-
-
0027289296
-
Spectrum of parimary cutaneous CD30 (Ki-1)- positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment
-
Willemze R, Beljaards RC: Spectrum of parimary cutaneous CD30 (Ki-1)- positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 28:973-980,1993.
-
(1993)
J Am Acad Dermatol
, vol.28
, pp. 973-980
-
-
Willemze, R.1
Beljaards, R.C.2
-
26
-
-
0027400943
-
Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients
-
Beljaards RC, Kaudewitz P, Berti E, et al: Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer 71:2097-2104, 1993.
-
(1993)
Cancer
, vol.71
, pp. 2097-2104
-
-
Beljaards, R.C.1
Kaudewitz, P.2
Berti, E.3
-
27
-
-
0029036853
-
CD30/Ki-1+ lymphoproliferative disorders of the skin: Clinicopathologic correlation and statistical analysis of 86 cases
-
Paulli M, Berti E, Rosso R, et al: CD30/Ki-1+ lymphoproliferative disorders of the skin: Clinicopathologic correlation and statistical analysis of 86 cases. J Clin Oncol 12:1343-1354, 1995.
-
(1995)
J Clin Oncol
, vol.12
, pp. 1343-1354
-
-
Paulli, M.1
Berti, E.2
Rosso, R.3
-
28
-
-
0031884013
-
Primary cutaneous large-cell lymphoma. Analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe dEtude des Lymphomas de lAdulte
-
Brice R, Cazals D, Mounier N, et al: Primary cutaneous large-cell lymphoma. Analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe dEtude des Lymphomas de lAdulte. Leukemia 12:213-219, 1998.
-
(1998)
Leukemia
, vol.12
, pp. 213-219
-
-
Brice, R.1
Cazals, D.2
Mounier, N.3
-
30
-
-
3142655707
-
Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara)
-
Didona B, Benucci R, Amerio P, et al. Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara). Br J Dermatol 150:1198-201, 2004.
-
(2004)
Br J Dermatol
, vol.150
, pp. 1198-1201
-
-
Didona, B.1
Benucci, R.2
Amerio, P.3
-
31
-
-
70349662167
-
A phase II study of SGN-30 (anti-CD30 monoclonal antibody) in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disorders
-
Duvic M, Reddy SA, Pinter-Brown L, et al: A phase II study of SGN-30 (anti-CD30 monoclonal antibody) in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disorders. Clin Cancer Res 15:6217-6224, 2009.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 6217-6224
-
-
Duvic, M.1
Reddy, S.A.2
Pinter-Brown, L.3
-
32
-
-
0028012062
-
Prognostic factors in aggressive non-Hodgkins lymphoma: Who has high-risk disease?
-
Shipp MA: Prognostic factors in aggressive non-Hodgkins lymphoma: Who has high-risk disease? Blood 83:1165-1173, 1994.
-
(1994)
Blood
, vol.83
, pp. 1165-1173
-
-
Shipp, M.A.1
|